Inhibition of ATR by caffeine treatment, ATR inactivating mutation, or genetic knockdown resulted in the depletion of CD133+ colon cancer stem cells and reduced in vivo tumorigenicity in the xenograft mouse model. Here, PROM1 is linked to malignant colon neoplasm.